APOLLO HOSPITALS ENTER. L vs CONCORD BIOTECH LIMITED
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and CONCORD BIOTECH LIMITED (CONCORDBIO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
APOLLO HOSPITALS ENTER. L vs CONCORD BIOTECH LIMITED are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation13
- Profitability13
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
CONCORDBIO takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
CONCORDBIO takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 28.2%"]
- − ["Stock is trading at 7.67 times its book value", "The company has delivered a poor sales growth of 11.3% over past five years.", "Company has high debtors of 159 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.